<DOC>
	<DOCNO>NCT00861614</DOCNO>
	<brief_summary>The purpose study determine advance prostate cancer patient treat radiotherapy ( RT ) plus ipilimumab live longer treat RT alone</brief_summary>
	<brief_title>Study Immunotherapy Treat Advanced Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com . Advanced prostate cancer At least 1 bone metastasis Testosterone &lt; 50 ng/dl Prior treatment docetaxel Brain metastasis Autoimmune disease Known HIV , Hep B , Hep C infection More 2 prior systemic anticancer regimen prostate cancer Prior treatment BMS CA180227 prostate cancer</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>